Yahoo! Finance: Biotechnology Industry News: Achillion's Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

TypePad Has the Tools Looking for a premiere blogging service? Start your blog today on TypePad. From our sponsors

Achillion's Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile Nov 2nd 2013, 13:05 [GlobeNewswire] - NEW HAVEN, Conn. -- Achillion Pharmaceuticals, Inc. today announced a poster presentation detailing the preclinical profile of ACH-3422, a uridine-analog nucleotide prodrug being advanced for the potential ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions